SARS-CoV-2 Vaccine

Patients with liver diseases, especially those with cirrhosis, have an increased mortality risk when infected by SARS-CoV-2 and therefore anti-SARS-CoV-2 vaccine has been recommended by leading Scientific Associations for all patients with chronic liver diseases. However, previous reports have shown a reduced antibody response following the full course of vaccination in immunosuppressed patients, including liver transplant recipients and several rheumatic diseases.
Elsevier, The Lancet Planetary Health, Volume 5, October 2021
Development COVID-19 vaccines in a record time has been an unprecedented global scientific achievement. However, the world has failed to ensure equitable access to what should have been a global public good. What options remain available to African countries to ensure immunization of their populations and ultimately overcome the pandemic?
This Comment, written by two Black emergency room physicians, supports SDGs 3 and 10 by highlighting low vaccination rates for COVID-19 among Black Americans. The authors explain the historical context that has led to mistrust of the health-care system among many in the Black community and present COVID-19 vaccination as an opportunity to begin to make amends.